Larotrectinib Capsules and Novoeight
Determining the interaction of Larotrectinib Capsules and Novoeight and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Capsules-Novoeight recombinant
- Larotrectinib Capsules-Novolin 70/30
- Larotrectinib Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Larotrectinib Capsules-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Larotrectinib Capsules-Novolin N
- Larotrectinib Capsules-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Novoeight-Larotrectinib Oral Solution
- Novoeight-Larotrectinib Sulfate
- Novoeight-Lartruvo
- Novoeight-Larynex
- Novoeight-Laryng-O-Jet
- Novoeight-Laryngesic